---
schema_version: "secwatch.filing_event.v1"
accession: "0001437749-26-015039"
form_type: "8-K"
ticker: "PLSE"
cik: "0001625101"
company_name: "PULSE BIOSCIENCES, INC."
filed_at: "2026-05-06T23:59:59+00:00"
generated_at: "2026-05-14T22:45:12.481791+00:00"
event_type: "other_material"
sentiment: "positive"
materiality_score: 0.5
calibrated_materiality_score: 0.5
confidence: "high"
source: SEC EDGAR
---

# Pulse Biosciences expands ATM to allow insider purchases; major holder and CEO indicate likely buying

## Summary
- Board authorized TD Cowen to sell shares to affiliates under existing ATM with up to $60M aggregate offering.
- Robert Duggan (72% owner) and CEO Paul LaViolette indicate they are likely to purchase shares in near term.
- No binding commitments or share counts; purchases would be at prevailing market bid or better.

## SEC filing metadata
- accession: 0001437749-26-015039
- form_type: 8-K
- ticker: PLSE
- cik: 0001625101
- company_name: PULSE BIOSCIENCES, INC.
- filed_at: 2026-05-06T23:59:59+00:00
- event_type: other_material
- sentiment: positive
- materiality_score: 0.5
- calibrated_materiality_score: 0.5
- confidence: high
- sec_items: 8.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1625101/000143774926015039/0001437749-26-015039-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1625101/000143774926015039/plse20260505_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001437749-26-015039
- JSON: https://secwatch.observer/filing/0001437749-26-015039.json
- Plain text: https://secwatch.observer/filing/0001437749-26-015039.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.